BHCM
DCPH

Boulder Hill Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Boulder Hill Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,400
Closed -$220K – 228
2022
Q4 		$220K Buy
+13,400
New +$218K 0.18% 109

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boulder Hill Capital Management's DCPH Position: Q1 2023 in Review

Boulder Hill Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2023, closing a stake of 13,400 shares — an estimated $220K sold.

Boulder Hill Capital Management first reported a position in DCPH in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 146 funds tracked by Wall St. Rank hold DCPH as of Q1 2023.

  • Boulder Hill Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 13,400 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $220K.
  • Boulder Hill Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Boulder Hill Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $220K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Boulder Hill Capital Management's 13F filing for Q1 2023, filed 12 May 2023.